Showing 2671-2680 of 3872 results for "".
- ASDS Abstract Highlights Potential of ALA-PDThttps://modernaesthetics.com/news/asds-abstract-highlights-potential-of-ala-pdt/2473704/Photodynamic therapy (PDT) with aminolevulonic acid (ALA) was the topic of the top 10 abstract “Fine Wrinkles and the Art of Light,” presented by Luke Horton, MD, at the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting. Dr. Horton performed a study along
- Botox Approved for Platysma Bandshttps://modernaesthetics.com/news/botox-approved-for-platysma-bands/2473696/The US Food and Drug Administration (FDA) has approved BOTOX® Cosmetic for temporary improvement in the appearance of moderate-to-severe vertical bands connecting the jaw and neck (platysma bands) in adults, Allergan Aesthetics, an AbbVie company, announced. According to a pres
- Allergan Aesthetics to Present New Data at 2024 ASDS Conferencehttps://modernaesthetics.com/news/allergan-aesthetics-to-present-new-data-at-2024-asds-conference/2473693/Allergan Aesthetics will be presenting new data at the 2024 American Society for Dermatologic Surgery (ASDS) conference, which is underway through October 20. The data will showcase efficacy, safety and patient-reported outcomes across its facial injectable portfolio. Four of the 12 abs
- Global Aesthetic Threads Market to Grow More Than $100B Next 10 Yearshttps://modernaesthetics.com/news/global-aesthetic-threads-market-to-grow-more-than-100b-next-10-years/2473687/The global aesthetic threads market size is estimated to be worth $147.20 billion this year, but by 2033 the market is forecasted grow by more than $100 billion. From 2025 to 2033 the market is expected to reach $253.55 billion, according to Straits Research. The compound annual g
- AEON 'Aligned' With FDA for Botox Biosimilarhttps://modernaesthetics.com/news/aeon-aligned-with-fda-for-botox-biosimilar/2473682/AEON Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, announced receipt of the formal minutes from a recent Biosimilar Initial Advisory (BIA) Meeting with the US Food and Drug Administration (FDA) for AB
- Report: Nonsurgical Aesthetics Revenues Up 9% From Last Yearhttps://modernaesthetics.com/news/report-nonsurgical-aesthetics-revenues-up-9-from-last-year/2473677/Data and analytics solutions provider Guidepoint Qsight and investment banking and management consulting firm Skytale Group released a new report on the state of the aesthetics industry, highlighting the continued expansion of the US market. Combined nonsurgical revenues increased by 9%
- New Noninvasive Treatment Boasts Long-Lasting Lift, Zero Downtimehttps://modernaesthetics.com/news/new-noninvasive-treatment-boasts-long-lasting-lift-zero-downtime/2473674/Merz Aesthetics announced the launch of Ultherapy PRIME, a noninvasive treatment that the company says provides a truly personalized and long-lasting lift of the skin in one session with zero downtime. “The Ultherapy PRIME platform is the evolution of Ultherapy®, which has bee
- Ozempic Potentially Linked to Facial Edema After Fillerhttps://modernaesthetics.com/news/ozempic-potentially-linked-to-facial-edema-after-filler/2473672/The authors of a recent Journal of Craniofacial Surgery article speculate that some medications may be capable of initiating immune responses, such as facial edema. Dr. Nathaly de Oliveira Ciaramicolo and co-authors discussed a case of a patient who presented with significant facial ede
- Allergan Aesthetics, University Lab Announce Winner of Golden Ticket Pitch Competitionhttps://modernaesthetics.com/news/allergan-aesthetics-university-lab-announce-winner-of-golden-ticket-pitch-competition/2473666/Allergan Aesthetics and University Lab Partners (ULP) announced NovoThelium as the winner of the 2nd annual Golden Ticket Pitch Competition for aesthetic startups. The Golden Ticket competition accelerates the research and development of startup aesthetics enterprises by offering the winner
- Hyperpigmentation Treatment Market Valued at $5.48Bhttps://modernaesthetics.com/news/hyperpigmentation-treatment-market-valued-at-548b/2473664/Hyperpigmentation is the darkening of the skin caused by the overproduction of melanin, leading to conditions such as melasma, post-inflammatory hyperpigmentation, and sunspots. The global hyperpigmentation treatment market was valued at approximately $5.48 billion in 2023, according to Ocean Rep